PedAM
Pediatric Disease Annotations & Medicines
| pulmonary alveolar microlithiasis | ||||
| Disease ID | 196 |
|---|---|
| Disease | pulmonary alveolar microlithiasis |
| Definition | Pulmonary alveolar microlithiasis (PAM) is a rare, inherited disorder of lung phosphate balance that is associated with small stone formation in the airspaces of the lung. Mutations in the gene SLC34A2[1][2] result in loss of a key sodium, phosphate co-transporter (called Npt2b), known to be expressed in distal airway epithelial alveolar type II cells, as well as in the mammary gland, and to a lesser extent in intestine, kidney, skin, prostate and testes. As the disease progresses, the lung fields become progressively more dense (white) on the chest xray, and low oxygen level, lung inflammation and fibrosis, elevated pressures in the lung blood vessels, and respiratory failure ensue, usually in middle age. The clinical course of PAM can be highly variable, with some patients remaining asymptomatic for decades, and others progressing more rapidly. There is no effective treatment, and the mechanisms of stone formation, inflammation and scarring are not known. - Wikipedia Reference: https://en.wikipedia.org/wiki/pulmonary alveolar microlithiasis |
| Synonym | alveolar microlithiasis alveolar microlithiasis pulmonary lung, alveolar microlithiasis pam - pulmonary alveolar microlithiasis pulm alveolar microlith pulmonary alveolar microlithiasis (disorder) |
| Orphanet | |
| OMIM | |
| DOID | |
| ICD10 | |
| UMLS | C0155912 |
| SNOMED-CT | |
| Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:6) |
| Curated Gene | Entrez_id | Symbol | Resource(Total Genes:1) |
| Inferring Gene | (Waiting for update.) |
| Text Mined Gene | Entrez_id | Symbol | Score | Resource(Total Genes:8) |
| Locus | Symbol | Locus(Total Locus:1) SLC34A2 | 4p15.2 |
| Disease ID | 196 |
|---|---|
| Disease | pulmonary alveolar microlithiasis |
| Integrated Phenotype | HPO | Name(Total Integrated Phenotypes:3) HP:0006514 | Intraalveolar nodular calcifications HP:0006520 | Progressive pulmonary function impairment HP:0002111 | Restrictive respiratory insufficiency' |
| Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:5) |
| Disease ID | 196 |
|---|---|
| Disease | pulmonary alveolar microlithiasis |
| Manually Symptom | UMLS | Name(Total Manually Symptoms:4) |
| Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
|---|
| (Waiting for update.) |
All Snps(Total Genotypes:3) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
| rs137853141 | NA | 10568 | SLC34A2 | umls:C0155912 | CLINVAR | NA | 0.481628651 | NA | SLC34A2 | 4 | 25662818 | C | T |
| rs137853142 | NA | 10568 | SLC34A2 | umls:C0155912 | CLINVAR | NA | 0.481628651 | NA | SLC34A2 | 4 | 25664267 | G | A,C |
| rs796065044 | NA | 10568 | SLC34A2 | umls:C0155912 | CLINVAR | NA | 0.481628651 | NA | SLC34A2 | 4 | 25662804 | ACCTACCCACTCT | - |
GWASdb Annotation(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
GWASdb Snp Trait(Total Genotypes:0) | |
|---|---|
| (Waiting for update.) | |
Mapped by lexical matching(Total Items:0) |
|---|
| (Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
|---|
| (Waiting for update.) |
Chemical(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |
FDA approved drug and dosage information(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |
FDA labeling changes(Total Drugs:0) | |
|---|---|
| (Waiting for update.) | |